Detalles de la búsqueda
1.
Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody.
Oncologist
; 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38478404
2.
Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study.
Ann Surg Oncol
; 31(5): 3073-3083, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38316732
3.
A new scoring system for predicting the outcome of hepatocellular carcinoma patients without microvascular invasion-a large-scale multicentre study.
HPB (Oxford)
; 26(6): 741-752, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38472016
4.
Impact of Bile Duct Tumor Thrombus on the Long-Term Surgical Outcomes of Hepatocellular Carcinoma Patients: A Propensity Score Matching Analysis.
Ann Surg Oncol
; 29(2): 949-958, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34591226
5.
Postoperative adjuvant transarterial chemoembolization improves outcomes of hepatocellular carcinoma associated with bile duct tumor thrombus: a propensity score matching analysis.
HPB (Oxford)
; 24(4): 547-557, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34635434
6.
Recurrence hazard rate in patients with hepatocellular carcinoma and bile duct tumor thrombus: a multicenter observational study.
HPB (Oxford)
; 24(10): 1703-1710, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35523655
7.
Should associating liver partition and portal vein ligation for staged hepatectomy be applied to hepatitis B virus-related hepatocellular carcinoma patients with cirrhosis? A multi-center study.
HPB (Oxford)
; 24(12): 2175-2184, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36280426
8.
Long-Term Outcomes of Anatomic Versus Nonanatomic Resection in Hepatocellular Carcinoma Patients with Bile Duct Tumor Thrombus: A Propensity Score Matching Analysis.
Ann Surg Oncol
; 28(12): 7686-7695, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33929619
9.
A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma.
BMC Cancer
; 21(1): 272, 2021 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33711965
10.
ASO Author Reflections: Impact of Salvage Surgery in Unresectable Hepatocellular Carcinoma After Conversion Therapy: Should it be Recommended?
Ann Surg Oncol
; 31(5): 3100-3101, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38300403
11.
ASO Author Reflections: Impact of Bile Duct Tumor Thrombus in Hepatocellular Carcinoma-Does it Influence Staging Systems?
Ann Surg Oncol
; 29(2): 959, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34596793
12.
Correction to: Impact of Bile Duct Tumor Thrombus on the Long-Term Surgical Outcomes of Hepatocellular Carcinoma Patients: A Propensity Score Matching Analysis.
Ann Surg Oncol
; 29(6): 3981, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35066723
13.
ASO Author Reflections: Treatment for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus-Anatomic Resection Should Be Recommended.
Ann Surg Oncol
; 28(12): 7696-7697, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33791902
14.
A new species and a replacement name in Cynanchum (Apocynaceae, Asclepiadeae) from China.
PhytoKeys
; 241: 49-63, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38628636
15.
The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors.
Hepatol Int
; 18(2): 651-660, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38040945
16.
Transcatheter arterial chemoembolisation combined with lenvatinib plus camrelizumab as conversion therapy for unresectable hepatocellular carcinoma: a single-arm, multicentre, prospective study.
EClinicalMedicine
; 67: 102367, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38169778
17.
Long-term surgical outcomes of bile duct tumor thrombus versus portal vein tumor thrombus for hepatocellular carcinoma: a propensity score matching analysis.
Front Oncol
; 14: 1372123, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38628666
18.
Short-term and long-term outcomes after robotic versus open hepatectomy in patients with large hepatocellular carcinoma: a multicenter study.
Int J Surg
; 110(2): 660-667, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37983785
19.
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.
Nat Med
; 30(3): 708-715, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38242982
20.
Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Transcatheter Arterial Chemoembolization Therapy.
J Hepatocell Carcinoma
; 10: 1827-1837, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37850079